BNCM Announces 11 New Products from DELEX PHARMA to Propel Growth

3rd September 2024, Quezon City, Philippines Delex Pharma International Inc. has launched an impressive array of 11 new pharmaceutical products in the first half of 2024, setting the stage for significant growth across multiple therapeutic areas. This launch reflects Delex Pharma’s commitment to addressing critical healthcare needs in the Philippines, particularly in the fields of critical care, oncology, anesthesia, and medical devices.